Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioXcel Therapeutics (BTAI) Times Interest Earned (2022 - 2025)

BioXcel Therapeutics has reported Times Interest Earned over the past 4 years, most recently at -$2.62 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$2.62 for Q4 2025, down 6.72% from a year ago — trailing twelve months through Dec 2025 was -$3.2 (up 26.85% YoY), and the annual figure for FY2025 was -$3.29, up 25.95%.
  • Times Interest Earned for Q4 2025 was -$2.62 at BioXcel Therapeutics, up from -$3.25 in the prior quarter.
  • Over the last five years, Times Interest Earned for BTAI hit a ceiling of -$2.45 in Q4 2024 and a floor of -$4497.1 in Q1 2022.
  • Median Times Interest Earned over the past 4 years was -$8.17 (2023), compared with a mean of -$290.27.
  • Peak annual rise in Times Interest Earned hit 99.62% in 2023, while the deepest fall reached 40.93% in 2023.
  • BioXcel Therapeutics' Times Interest Earned stood at -$25.68 in 2022, then skyrocketed by 62.46% to -$9.64 in 2023, then surged by 74.55% to -$2.45 in 2024, then decreased by 6.72% to -$2.62 in 2025.
  • The last three reported values for Times Interest Earned were -$2.62 (Q4 2025), -$3.25 (Q3 2025), and -$4.14 (Q2 2025) per Business Quant data.